EU Grants

The mission of the EU-funded BIGPICTURE project is to establish the first European platform where quality-controlled whole slide imaging (WSI) data are stored. The consortium consists of Europe's largest pathology departments and will work towards an open-source framework for accessing, annotating and mining WSI data using AI algorithms. With access to millions of WSI data, BIGPICTURE envisions AI-based methods that can help clinicians interpret tissue features and perform diagnosis fast, in a high-throughput manner, avoiding human bias or error.

BBMRI-ERIC's ELSI, Public Affairs, and OEC teams and their linked third parties contribute to this project.

In canSERV, European wide research infrastructures, oncology experts, and patient associations team up to battle cancer by providing transnational access to cutting-edge transnational research services. 

To offer at least 200 different unique Personalized Oncology (PO) relevant and valuable cutting-edge services for life science research in Europe over the next three years.

The project will establish a single, unified, transnational access platform to request services and training; ensure the FAIR compliance of oncology-related data; and sustain the network and unified resources of oncology-related service provision beyond the duration of the project. 

BBMRI-ERIC's PM, Finance, Biobanking Development, QM and OEC teams and their linked third parties contribute to this project.

The ERICs (European Research Infrastructure Consortia), under the umbrella of the ERIC Forum, represent one of the leading science policy voices in Europe and play a key role in structuring the research infrastructure landscape.

Following the successful set-up and implementation of the ERIC Forum (2019-2022), further efforts are needed to consolidate its achievements and expand the coordination and monitoring of the ERICs. This project aims to structure the cooperation between ERICs, support the implementation of the ERIC Regulation and ERICs services, and consolidate the integration of the ERICs in the European Research Area by deepening the ERIC Forum’s contribution to research policies.
To reach its objectives, the project relies on a multi-disciplinary consortium involving all identified ERICs, both multi and single-sited, and representing the five science clusters of the ERICs.

CETOCOEN Excellence will exploit research capacities built in Central Europe with support from the European Structural and Investment Fund and develop a cutting-edge research platform capable of addressing major scientific and societal challenges in contemporary Europe in the areas of environment and health.

BBMRI-ERIC's CS IT team and its linked third parties contribute to this project.

PROPHET will engage organisations and individuals in order to contribute to building a Strategic Research Innovation Agenda to adopt Personalised Prevention approaches into EU health systems.

The project aims to deliver specific measures to educate and empower different stakeholder groups to play an active role in self-care and to build a Personalised Prevention Roadmap for future healthcare that supports the definition and implementation of innovative, sustainable and high-quality personalised strategies to effectively prevent chronic diseases.

BBMRI-ERIC's ELSI, Public Affairs, and OEC teams and their linked third parties contribute to this project.

With a consortium of 35 partners, QUANTUM is an EU-funded project that aims to create a common label system for Europe that guarantees the quality and utility of datasets for scientific and health innovation purposes. These labels will enable researchers, policymakers, and healthcare professionals to identify high-quality data for research and decision making.

BBMRI-ERIC's IT and QM teams and their linked third parties contribute to this project.

The aim of HealthyCloud is to generate guidelines, recommendations and specifications that will enable distributed health research across Europe in the form of a Ready-to-implement Roadmap. This roadmap together with the feedback gathered from a broad range of stakeholders will be the basis to produce the final HealthyCloud Strategic Agenda for the European Health Research and Innovation Cloud (HRIC).

BBMRI-ERIC's ELSI team, IT, PM, OEC teams and their linked third parties contribute to this project.

EP PerMed is a new European Partnership dedicated to Personalised Medicine (PM). It supports PM-related R&I, but also facilitates and accelerates all steps so that PM achievements successfully pass through the full value continuum to be implemented in sustainable health systems for the benefit of people and societies. The partnership will foster demonstration projects and promote successes and lessons learned to demonstrate evidence of PM implementation. EP PerMed activities cover overarching aspects, like patient involvement, exchange with medical societies, infrastructures and international and regional collaboration. The project portfolios of EP PerMed and ERA PerMed (ERA-Net co-fund on PM) and others are supported to become successful innovations in healthcare practice. EP PerMed will be the global PM-platform for scientific and strategic dialogue and alignment, resulting in public documents and publications. Accordingly, it will inform the public, patients, healthcare providers or payers about the latest PM options and engage them. The Strategic Research and Innovation Agenda for Personalised Medicine (SRIA for PM, 2023), developed by EP PerMed partners, is the basis for the partnership's structure and a wide range of its activities. All steps of the SRIA development were strongly support by numerous PM-experts, stakeholders and the European Commission (EC). Thus, the EP PerMed annual Joint Transnational Calls (JTCs) and other funding and activities, events and tools will be in line with the SRIA and outputs will feed into a SRIA update in the coming years. The partnership builds on several developments, initiatives and projects such as ERA PerMed, ICPerMed and its supporting projects (“ICPerMed Family”) funded by the EC. In parallel, it reaches out to the 1+Million Genomes Initiative, other European Partnerships in the Health Cluster and infrastructures like the European Strategy Forum on Research Infrastructures (ESFRI).

The EvolveBBMRI project aims to further develop BBMRI-ERIC for the benefit of its scientific communities and users, increase its capacity to serve EU policy priorities, and further deepen its collaboration with industry. The project is structured in four thematic pillars: 1) Acceleration of datafication of biobanks and biomolecular resources to enable reproducible advanced medical research in support of EU health priorities; 2) teaming up with industry to facilitate greener biobanking; 3) setting long-term sustainability measures for BBMRI that also address RI landscape gaps; and 4) strengthened approaches related to career paths, training and outreach activities to maximise impact.

The Genomic Data Infrastructure (GDI) project enables access to genomic and related phenotypic and clinical data across Europe by establishing a federated, sustainable and secure infrastructure to access the data. It builds on the outputs of the Beyond 1 Million Genomes (B1MG) project and is realising the ambition of the 1+Million Genomes (1+MG) initiative.

The INTEGRATE-LMedC consortium will develop a new concept to guide and support decision-making for the next-generation research infrastructure (RI) to facilitate efficient utilization and harmonization of large medical cohorts (LMedC), and to accelerate scientific and medical breakthroughs in Europe and beyond. Achievement of the ambitious objectives will only be possible through the integration of 11 highly interdisciplinary partners including established ERIC / ESFRI infrastructures such BBMRI, ECRIN, EIRENE and EBRAINS with unique expertise in conceptualizing and implementing European RIs. The partners will generate a gap analysis to identify what is missing of cohort data and samples, RI tools and services, quality measures, governance models, user needs and the barriers for efficient utilization of these cohorts and RI, including ethical and legal frameworks. To identify IT technologies and architecture for suitable data stewardship and long-term availability of European RIs, the partners will prepare for a feasibility study for federated data analysis of LMedC. The feasibility study will be based on two examples of use-cases: one stroke case using data from medical health registry data and one case using data from longitudinal population-based studies with different technical, legal, and ethical challenges. To ensure availability of data and samples related to existing and future LMedC studies and their re-use for secondary research, the partners will develop a concept outline including a governance plan and guiding principles for data access policies and data protection policy, whilst considering the FAIR principles and ELSI issues. An overarching RI concept to manage, integrate, and sustain LMedC studies will be developed, including an initial financial and operational plan for the implementation of the new RI outlining new services and access opportunities for the research community.

Scientific discoveries increasingly rely on data and AI. Research infrastructures (RIs) generate huge amounts of complex data, but managing, analysing and using this information is becoming a major challenge. Scientists often lack the large-scale tools and expertise needed to process data quickly and effectively. With this in mind, the EU-funded RI-SCALE project is tackling this issue by creating scalable Data Exploitation Platforms. These platforms will combine scientific data with preconfigured AI tools and powerful computing resources, unlocking their full potential. Working with four RIs (ENES, EISCAT, BBMRI and Euro-BioImaging), RI-SCALE will test the technology in environmental and life sciences. It will also foster collaborations to help more RIs adopt these innovations.